, Singapore

SIAEC to provide engine maintenance to France's Safran Aircraft Engines

They will provide engine Quick Turn (QT) and modification embodiment services.

SIA Engineering Company (SIAEC) will be providing engine maintenance service to French aerospace engine manufacturer Safran Aircraft Engines after signing an agreement, according to a press release.

The 10-year agreement includes engine Quick Turn (QT) and modification embodiment services for both CFM LEAP-1A and LEAP-1B engines. SIAEC will also set up a facility that seeks to have the latest engine and QT processes to support these services, which is expected to begin operations in 2020.

The LEAP-1A is one of two engine options for the Airbus A320neo family, whilst the LEAP-1B is the exclusive engine for the Boeing 737 MAX. The LEAP engine is a product of CFM International, a 50/50 joint company between US-based GE and France-based Safran Aircraft Engines (France).

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare